Christoph Hagemeyer, a chemist by training, obtained a PhD in Biochemistry from the University of Freiburg (Germany). He made contributions to the field of Cytochrome P450 metabolism in the rodent brain before moving into cardiovascular research developing anti-thrombotic recombinant fusion proteins and novel imaging probes. He migrated to Australia in 2005 and is currently Head of the NanoBiotechnology Laboratory at Monash University’s Australian Centre for Blood Diseases. His main research interests are drug delivery, molecular imaging and novel bioconjugation techniques in thrombosis, inflammation and cancer.
HUP3011 - Human pathology: Atherosclerosis
HUP3011 - Human pathology: Vascular biology and disease
IMM3042 - Clinical immunopathology: Recombinant antibodies in immunotherapy
MED2031 - Medicine: Coronary circulation in health and disease
Central Clinical School Honours program "PET / CT Imaging Technology"